CAS: 1164464-14-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | TG 6-129 REF: TR-T337945CAS: 1164464-14-5 | - - - | 2,137.00 € | Tue 21 Jan 25 |
 | TG 6-129 REF: 3D-PWB46414CAS: 1164464-14-5 | Min. 95% | To inquire | Tue 21 Jan 25 |
 | TG6-129 REF: TM-T28958CAS: 1164464-14-5 | 98.39% | 119.00 €~2,617.00 € | Tue 11 Feb 25 |
TG 6-129
Controlled ProductCAS:1164464-14-5
Formula:
C20H18FN5O3S3
Color and Shape:
Neat
Molecular weight:
491.582
Ref: TR-T337945
| 100mg | 2,137.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
TG 6-129
CAS:1164464-14-5
TG 6-129 is a peptide that interacts with the receptor of the human protein C-reactive …
Formula:
C20H18FN5O3S3
Purity:
Min. 95%
Molecular weight:
491.6 g/mol
Ref: 3D-PWB46414
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
TG6-129
CAS:1164464-14-5
TG6-129 is an EP2 receptor antagonist, blocking PGE2 effects, reducing inflammatory markers with 1.6 µM …
Formula:
C20H18FN5O3S3
Purity:
98.39%
Color and Shape:
Solid
Molecular weight:
491.58
Ref: TM-T28958
| 1mg | 119.00 € | ||
| 5mg | 237.00 € | ||
| 10mg | 419.00 € | ||
| 25mg | 686.00 € | ||
| 50mg | 917.00 € | ||
| 100mg | 1,291.00 € | ||
| 500mg | 2,617.00 € | ||
| 1mL*10mM (DMSO) | 337.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
